EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 28.99 ($0.37) and traded as low as GBX 25 ($0.32). EKF Diagnostics shares last traded at GBX 25 ($0.32), with a volume of 144,190 shares.
EKF Diagnostics Stock Down 1.6 %
The firm has a market cap of £113.43 million, a PE ratio of 2,500.00 and a beta of 0.57. The company has a current ratio of 4.59, a quick ratio of 1.77 and a debt-to-equity ratio of 1.78. The stock has a fifty day simple moving average of GBX 28.46 and a two-hundred day simple moving average of GBX 28.99.
About EKF Diagnostics
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
See Also
- Five stocks we like better than EKF Diagnostics
- Where Do I Find 52-Week Highs and Lows?
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- How to Invest in the FAANG Stocks
- Top-Performing Non-Leveraged ETFs This Year
- Stock Dividend Cuts Happen Are You Ready?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
